Robert Flaherty Joins Behrman Capital

Robert Flaherty has joined Behrman Capital as an operating partner, with a focus on the healthcare sector. He is the former CEO of Athena Diagnostics, which Behrman acquired and then sold to Fisher Scientific International for $283 million.

15 May 2009•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles